Ovarian Cancer Second Edition /
Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of effective tumor-specific therapeutics. Ovarian carcinogenesis, invasion, and...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Boston, MA :
Springer US,
2010.
|
Έκδοση: | 2. |
Σειρά: | Cancer Treatment and Research,
149 |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Chemoprevention, Staging, and Novel Therapeutic Targets
- Chemoprevention of Ovarian Cancer
- Staging and Surgical Treatment
- Novel Therapeutic Targets
- Biomarker Targets and Novel Therapeutics
- Tumorigenesis and Biomarkers
- Tumor Suppressor Genes
- Epigenetics and Ovarian Cancer
- Aberrant Epithelial Differentiation in Ovarian Cancer
- The Human Kallikrein Gene Family: New Biomarkers for Ovarian Cancer
- Soluble Epidermal Growth Factor Receptor: A Biomarker of Epithelial Ovarian Cancer
- Activated Epidermal Growth Factor Receptor in Ovarian Cancer
- Tumor Progression, Metastasis, Research Models
- Ras-Superfamily GTP-ases in Ovarian Cancer
- Lipid Generation and Signaling in Ovarian Cancer
- Lysophosphatidic Acid and Invasion
- Cell Adhesion in Ovarian Cancer
- Microenvironmental Regulation of Ovarian Cancer Metastasis
- Organotypic Models of Metastasis: A Three-dimensional Culture Mimicking the Human Peritoneum and Omentum for the Study of the Early Steps of Ovarian Cancer Metastasis
- Animal Models of Ovarian Cancer.